Oncology
Conference Coverage
T-DM1 Tops Capecitabine-Lapatinib in Advanced HER2-Positive Breast Cancer
Major Finding: Median progression-free survival was longer with T-DM1 than with capecitabine plus lapatinib (9.6 vs.
Conference Coverage
Intermittent Hormone Therapy Shortens Prostate Cancer Survival
Major Finding: Men with minimal disease lived a median of 5.2 years if randomized to intermittent androgen deprivation vs.
News
Vismodegib Proves Promising for Operable BCCs
Major Finding: Twelve weeks of once-daily oral vismodegib resulted in complete histologic clearance in 10 of 24 patients with newly diagnosed,...
News
Urologists Back PSA Screening; Rail Against USPSTF's Position
News
Daily Aspirin Reduced Recurrent Venous Thromboembolism
News
PSA Level Could Determine Screening Frequency in 40s
News
Concurrent Chemoradiotherapy Prolongs Survival for Elderly With NSCLC
Major Finding: The primary end point (overall survival) reached 22.4 months with chemoradiotherapy, significantly longer than the 16.9 months with...
News
U.S. Task Force Confirms Stance Against Universal PSA Screening
News
Routine Sigmoidoscopy Cut Colorectal Cancer Incidence, Mortality
Major Finding: The use of flexible sigmoidoscopy for colorectal cancer screening, as compared with usual care, was associated with a 26% reduction...
News
Obesity Linked to More Advanced and More Aggressive Thyroid Cancer
Major Finding: Obese and morbidly obese patients were significantly more likely than were thinner patients to have stage III or IV thyroid cancer...